$9.54
-0.83-8%
近くで: Nov 20, 4:00 PM EST
$9.90
0.363.77%
時間外: 7:32 PM EST
The average analyst price target for Generate Biomedicines is $26.20, 164.6% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $21 to $30. The latest change came on Nov 18, 2026, when Morgan Stanley lowered its price target on Generate Biomedicines from $22 to $21 and kept an Overweight rating.
Price Target Range — 4 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
